CIK 0000920148 · Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 992588107
- Phone
- 3362291127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,195,768
- in 4 filings, $1.1M under 10b5-1 plans
Net −$2,195,768. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-06 | Bailey Megan D. EVP, Pres, Central Labs & Intl | Shares withheld for taxes | −72 | $277.20 | $20K | 3,702 |
| 2026-02-06 | Bailey Megan D. EVP, Pres, Central Labs & Intl | Option exercise · Restricted Stock Unit | −180 | 2,419 | ||
| 2025-12-01 | Bulto Carulla Victor Director | Grant or award · Restricted Stock Unit | +136 | 136 | ||
| 2025-11-11 | Schechter Adam H President & CEO | Sale 10b5-1 | −5,745 | $262.75 | $1.5M | 87,574 |
| 2025-11-03 | Bailey Megan D. EVP, Pres, Central Labs & Intl | Shares withheld for taxes | −179 | $257.84 | $46K | 3,594 |
| 2025-11-03 | Oyegunwa Akinbolade EVP, CIO & CTO | Shares withheld for taxes | −107 | $257.84 | $28K | 3,727.25 |
| 2025-11-01 | Bailey Megan D. EVP, Pres, Central Labs & Intl | Option exercise | +370 | 3,773 | ||
| 2025-11-01 | Bailey Megan D. EVP, Pres, Central Labs & Intl | Option exercise · Restricted Stock Unit | −370 | 2,599 | ||
| 2025-11-01 | Oyegunwa Akinbolade EVP, CIO & CTO | Option exercise | +370 | 3,834.25 | ||
| 2025-11-01 | Oyegunwa Akinbolade EVP, CIO & CTO | Option exercise · Restricted Stock Unit | −370 | 1,939 | ||
| 2025-10-31 | Parham Richelle P Director | Sale | −7,009 | $254.28 | $1.8M | 2,469 |
| 2025-08-13 | van der Vaart Sandra D EVP, Chief Legal Officer | Option exercise | +3,903 | $131.43 | $513K | 6,176.67 |
| 2025-08-13 | van der Vaart Sandra D EVP, Chief Legal Officer | Sale | −3,903 | $271.42 | $1.1M | 2,273.67 |
| 2025-08-13 | van der Vaart Sandra D EVP, Chief Legal Officer | Option exercise · Non-qualified Stock Options | −3,903 | 0 | ||
| 2025-08-11 | Schechter Adam H President & CEO | Sale 10b5-1 | −5,643 | $266.78 | $1.5M | 93,319 |
| 2025-07-30 | Gilliland Dwight Gary Director | Sale | −2,000 | $264.95 | $530K | 6,656 |
| 2025-07-29 | Wilkinson Peter J SVP, Chief Accounting Officer | Sale | −102 | $261.01 | $27K | 1,952.22 |
| 2025-07-29 | Wilkinson Peter J SVP, Chief Accounting Officer | Sale | −100 | $261.04 | $26K | 1,852.22 |
| 2025-07-24 | ANDERSON KERRII B Director | Sale 10b5-1 | −3,500 | $280.00 | $980K | 8,666 |
| 2025-07-24 | ANDERSON KERRII B Director | Sale 10b5-1 | −3,500 | $280.00 | $980K | 8,666 |
Page 13 of 14 · 262 trades